Gonax 240mg subcutaneous injection (YJ code: 2499412D5020, standard: 240mg x 1 bottle (with dissolving solution)), manufactured by Ferring Pharma, contains degarelix acetate. This GnRH antagonist is used for prostate cancer treatment by suppressing testosterone secretion, and the 240 mg dosage is typically administered as an initial dose.
Gonax 240mg subcutaneous injection
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →